144 related articles for article (PubMed ID: 37963465)
1. Structural and signaling mechanisms of TAAR1 enabled preferential agonist design.
Shang P; Rong N; Jiang JJ; Cheng J; Zhang MH; Kang D; Qi L; Guo L; Yang GM; Liu Q; Zhou Z; Li XB; Zhu KK; Meng QB; Han X; Yan W; Kong Y; Yang L; Wang X; Lei D; Feng X; Liu X; Yu X; Wang Y; Li Q; Shao ZH; Yang F; Sun JP
Cell; 2023 Nov; 186(24):5347-5362.e24. PubMed ID: 37963465
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design of Novel G-Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic Drug Candidates.
Zhou Z; Zhang W; Zhao F; Sun Y; Wang N; Cheng J; Zhan P; Yang F; Sun JP; Liu X; Kang D
J Med Chem; 2024 Mar; 67(5):4234-4249. PubMed ID: 38416116
[TBL] [Abstract][Full Text] [Related]
3. In-vivo pharmacology of Trace-Amine Associated Receptor 1.
Lam VM; Espinoza S; Gerasimov AS; Gainetdinov RR; Salahpour A
Eur J Pharmacol; 2015 Sep; 763(Pt B):136-42. PubMed ID: 26093041
[TBL] [Abstract][Full Text] [Related]
4. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
[TBL] [Abstract][Full Text] [Related]
5. Ligand recognition and G-protein coupling of trace amine receptor TAAR1.
Xu Z; Guo L; Yu J; Shen S; Wu C; Zhang W; Zhao C; Deng Y; Tian X; Feng Y; Hou H; Su L; Wang H; Guo S; Wang H; Wang K; Chen P; Zhao J; Zhang X; Yong X; Cheng L; Liu L; Yang S; Yang F; Wang X; Yu X; Xu Y; Sun JP; Yan W; Shao Z
Nature; 2023 Dec; 624(7992):672-681. PubMed ID: 37935376
[TBL] [Abstract][Full Text] [Related]
6. Recognition of methamphetamine and other amines by trace amine receptor TAAR1.
Liu H; Zheng Y; Wang Y; Wang Y; He X; Xu P; Huang S; Yuan Q; Zhang X; Wang L; Jiang K; Chen H; Li Z; Liu W; Wang S; Xu HE; Xu F
Nature; 2023 Dec; 624(7992):663-671. PubMed ID: 37935377
[TBL] [Abstract][Full Text] [Related]
7. TAAR1 as an emerging target for the treatment of psychiatric disorders.
Liu J; Wu R; Li JX
Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862
[TBL] [Abstract][Full Text] [Related]
8. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
[TBL] [Abstract][Full Text] [Related]
10. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
Leo D; Targa G; Espinoza S; Villers A; Gainetdinov RR; Ris L
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887159
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists.
Kleinau G; Pratzka J; Nürnberg D; Grüters A; Führer-Sakel D; Krude H; Köhrle J; Schöneberg T; Biebermann H
PLoS One; 2011; 6(10):e27073. PubMed ID: 22073124
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach.
Garisetti V; Dhanabalan AK; Dasararaju G
Int J Biol Macromol; 2024 Apr; 264(Pt 2):130528. PubMed ID: 38431013
[TBL] [Abstract][Full Text] [Related]
13. Trace Amines and Their Receptors.
Gainetdinov RR; Hoener MC; Berry MD
Pharmacol Rev; 2018 Jul; 70(3):549-620. PubMed ID: 29941461
[TBL] [Abstract][Full Text] [Related]
14. Search for Structural Basis of Interactions of Biogenic Amines with Human TAAR1 and TAAR6 Receptors.
Glyakina AV; Pavlov CD; Sopova JV; Gainetdinov RR; Leonova EI; Galzitskaya OV
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008636
[TBL] [Abstract][Full Text] [Related]
15. TAAR Agonists.
Xu Z; Li Q
Cell Mol Neurobiol; 2020 Mar; 40(2):257-272. PubMed ID: 31848873
[TBL] [Abstract][Full Text] [Related]
16. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
[TBL] [Abstract][Full Text] [Related]
17. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
Harmeier A; Obermueller S; Meyer CA; Revel FG; Buchy D; Chaboz S; Dernick G; Wettstein JG; Iglesias A; Rolink A; Bettler B; Hoener MC
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2049-61. PubMed ID: 26372541
[TBL] [Abstract][Full Text] [Related]
18. Binding of SEP-363856 within TAAR1 and the 5HT
Nair PC; Miners JO; McKinnon RA; Langmead CJ; Gregory KJ; Copolov D; Chan SKW; Bastiampillai T
Mol Psychiatry; 2022 Jan; 27(1):88-94. PubMed ID: 34376825
[TBL] [Abstract][Full Text] [Related]
19. Amphetamines signal through intracellular TAAR1 receptors coupled to Gα
Underhill SM; Hullihen PD; Chen J; Fenollar-Ferrer C; Rizzo MA; Ingram SL; Amara SG
Mol Psychiatry; 2021 Apr; 26(4):1208-1223. PubMed ID: 31399635
[TBL] [Abstract][Full Text] [Related]
20. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
